Enhancement of the dissolution rate and bioavailability of fenofibrate by a melt-adsorption method using supercritical carbon dioxide

References

• AdkinsJCFauldsDMicronised fenofibrate: a review of its pharmacodynamic properties and clinical efficacy in the management of dyslipidemiaDrugs1997546156339339964
   PubMed Web of Science ®Google Scholar
• MurakamiHMurakamiRKambeFFenofibrate activates AMPK and increases eNOS phosphorylation in HUVECBiochem Biophy Res Commun2006341973978
   Web of Science ®Google Scholar
• JinnoJKamadaNMiyakeMEffect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogsJ Control Release2006111566416410029
   PubMed Web of Science ®Google Scholar
• HancockBCZografiGCharacteristics and significance of the amorphous state in pharmaceutical systemsJ Pharm Sci1997861129002452
   PubMed Web of Science ®Google Scholar
• Van NijlenTBrennanKVan den MooterGBlatonNKingetRAugustijnsPImprovement of the dissolution rate of artemisinin by means of supercritical fluid technology and solid dispersionsInt J Pharm200325417318112623193
   PubMed Web of Science ®Google Scholar
• RasenackNMuellerBWDissolution rate enhancement by in situ micronization of poorly water-soluble drugsPharm Res2002191894190012523671
   PubMed Web of Science ®Google Scholar
• KimM-SLeeSParkJ-SWooJ-SHwangS-JMicronization of cilostazol using supercritical antisolvent (SAS) process: effect of process parametersPowder Technol200717726470
   Web of Science ®Google Scholar
• HeikeFBerndFKarlKRolandBDissolution rate improvement of poorly water-soluble drugs obtained by adsorbing solutions of drugs in hydrophilic solvents onto high surface area carriersEur J Pharm Biopharm20066217117716275049
   PubMed Web of Science ®Google Scholar
• SharmaSSherPBadveSPawarAPAdsorption of meloxicam on porous calcium silicate: characterization and tablet formulationAAPS Pharm Sci Tech20056618625
   PubMed Web of Science ®Google Scholar
• SherPIngavleGPonrathnamSPawarAPLow density porous carrier: drug adsorption and release study by response surface methodology using different solventsInt J Pharm2007331728317030470
   PubMed Web of Science ®Google Scholar
• SubramaniamBRajewskiRASnavelyKPharmaceutical processing with supercritical carbon dioxideJ Pharm Sci1997868858909269864
   PubMed Web of Science ®Google Scholar
• JunSWKimM-SKimJ-SPreparation and characterization of simvastatin/hydroxypropyl-[beta]-cyclodextrin inclusion complex using supercritical antisolvent (SAS) processEur J Pharm Biopharm20076641342117240129
   PubMed Web of Science ®Google Scholar
• PasqualiIBettiniRGiordanoFSolid-state chemistry and particle engineering with supercritical fluids in pharmaceuticsEur J Pharm Biopharm200627299310
   Google Scholar
• SanganwarGPGuptaRBDissolution-rate enhancement of fenofibrate by adsorption onto silica using supercritical carbon dioxideInt J Pharm200836021321818550302
   PubMed Web of Science ®Google Scholar
• FischerKWilkenMGmehlingJThe effect of gas pressure on the melting behavior of compoundsFluid Phase Equilib2003210199214
   Web of Science ®Google Scholar
• GuptaMKVanwertABognerRHFormation of physically stable amorphous drugs by milling with NeusilinJ Pharm Sci20039253655112587115
   PubMed Web of Science ®Google Scholar
• GuptaMKGoldmanDBognerRHEnhanced drug dissolution and bulk properties of solid dispersions granulated with a surface adsorbentPharm Dev Technol2001656357211775957
   PubMed Web of Science ®Google Scholar
• TandyaADehghaniFFosterNRMicronization of cyclosporine using dense gas techniquesJ Supercrit Fluids200637272278
   Web of Science ®Google Scholar
• HusseinKTurkMWahlMADrug loading into [beta]-cyclodextrin granules using a supercritical fluid process for improved drug dissolutionEur J Pharm Sci20083330631218282694
   PubMed Web of Science ®Google Scholar
• DohrnRBertakisEBehrendOVoutsasETassiosDMelting point depression by using supercritical CO2 for a novel melt dispersion micronization processJ Mol Liq20071315359
   Web of Science ®Google Scholar
• StrumendoMBertuccoAElvassoreNModeling of particle formation processes using gas saturated solution atomizationJ Supercrit Fluids200741115125
   Web of Science ®Google Scholar
• KercJSrcicSKnezZMicronization of drugs using supercritical carbon dioxideInt J Pharm1999182333910332072
   PubMed Web of Science ®Google Scholar
• ChenY-MLinP-CTangMChenY-PSolid solubility of antilipemic agents and micronization of gemfibrozil in supercritical carbon dioxideJ Supercrit Fluids201052175182
   Web of Science ®Google Scholar
• HeinzAGordonKCMcGoverinCMRadesTStrachanCJUnderstanding the solid-state forms of fenofibrate – a spectroscopic and computational studyEur J Pharm Biopharm20097110010818590814
   PubMed Web of Science ®Google Scholar
• SrinarongPFaberJHVisserMRHinrichsWLJFrijlinkHWStrongly enhanced dissolution rate of fenofibrate solid dispersion tablets by incorporation of superdisintegrantsEur J Pharm Biopharm20097315416119465121
   PubMed Web of Science ®Google Scholar
• Sliwinska-BartkowiakMDudziakGGrasRSikorskiRRadhakrishnanRGubbinsKEFreezing behavior in porous glasses and MCM-41Colloids Surf A Physicochem Eng Asp2001187/188523529
   Web of Science ®Google Scholar
• ShenSCNgWKChiaLDongYCTanRBStabilized amorphous state of ibuprofen by co-spray drying with mesoporous SBA-15 to enhance dissolution propertiesJ Pharm Sci2009991997200719816955
   PubMed Web of Science ®Google Scholar
• WakayamaHGotoYFukushimaYA novel method for tailoring porous structures of nanoporous materials using supercritical solventsPhys Chem Chem Phys2003537843788
   Web of Science ®Google Scholar
• CharnayCBéguSTourné-PéteilhCNicoleLLernerDADevoisselleJMInclusion of ibuprofen in mesoporous templated silica: drug loading and release propertyEur J Pharm Biopharm20045753354015093603
   PubMed Web of Science ®Google Scholar
• KimJSKimMSParkHJJinSJLeeSHwangSJPhysicochemical properties and oral bioavailability of amorphous atorvastatin hemi-calcium using spray-drying and SAS processInt J Pharm200835921121918501538
   PubMed Web of Science ®Google Scholar
• KimMSJinSJKimJSPreparation, characterization and in vivo evaluation of amorphous atorvastatin calcium nanoparticles using supercritical antisolvent (SAS) processEur J Pharm Biopharm20086945446518359211
   PubMed Web of Science ®Google Scholar
• SugimotoMOkagakiTNarisawaSKoidaYNakajimaKImprovement of dissolution characteristics and bioavailability of poorly water-soluble drugs by novel cogrinding method using water-soluble polymerInt J Pharm19981601119
   Web of Science ®Google Scholar
• YamashitaKNakateTOkimotoKEstablishment of new preparation method for solid dispersion formulation of tacrolimusInt J Pharm2003267799114602386
   PubMed Web of Science ®Google Scholar
• VaughnJMMcConvilleJTCrispMTJohnstonKPWilliamsROSupersaturation produces high bioavailability of amorphous danazol particles formed by evaporative precipitation into aqueous solution and spray freezing into liquid technologiesDrug Dev Ind Pharm20063255956716720411
   PubMed Web of Science ®Google Scholar